Elizabeth A. Morgan
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 12
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Hematology top 2%
- Acute Myeloid Leukemia Research 16
-
- Lymphoma Diagnosis and Treatment 27
- Dermatology top 2%
- Cutaneous lymphoproliferative disorders research 12
- Oncology top 5%
- Viral-associated cancers and disorders 8
- CAR-T cell therapy research 7
- Vascular Tumors and Angiosarcomas 6
- Co-authors
- Lorraine S. SymingtonKatherine N. WeilbaecherAngela C. HirbeSylvie MoreauÖzge UluçkanGeraldine S. PinkusZuzana TóthováAlessandra F. Nascimento
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Elizabeth A. Morgan
89 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 119
- Genetics 682
- Hematology 535
- Pathology and Forensic Medicine 632
- Dermatology 266
- Oncology 811
Countries citing papers authored by Elizabeth A. Morgan
This map shows the geographic impact of Elizabeth A. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Morgan more than expected).
Fields of papers citing papers by Elizabeth A. Morgan
This network shows the impact of papers produced by Elizabeth A. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Morgan. The network helps show where Elizabeth A. Morgan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth A. Morgan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2021 | 4 | |
| 7 | 2020 | 9 | |
| 8 | 2020 | 12 | |
| 9 | 2019 | 9 | |
| 10 | 2017 | 8 | |
| 11 | 2017 | 13 | |
| 12 | 2016 | 227 | |
| 13 | 2016 | 144 | |
| 14 | 2016 | 189 | |
| 15 | 2016 | 46 | |
| 16 | 2014 | 10 | |
| 17 | 2011 | 115 | |
| 18 | CLINICAL FEATURES OF YOUNG ONSET PARKINSON'S DISEASE | 2009 | 1 |
| 19 | 2008 | 48 | |
| 20 | 2002 | 48 |
About Elizabeth A. Morgan
Elizabeth A. Morgan is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 93 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (27 papers), Acute Myeloid Leukemia Research (16 papers), Chronic Lymphocytic Leukemia Research (12 papers), Cutaneous lymphoproliferative disorders research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Viral-associated cancers and disorders (8 papers), CAR-T cell therapy research (7 papers) and Vascular Tumors and Angiosarcomas (6 papers). The work is most often cited by research in Genetics (682 citations), Hematology (535 citations) and Pathology and Forensic Medicine (632 citations). Elizabeth A. Morgan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Lorraine S. Symington, Katherine N. Weilbaecher, Angela C. Hirbe, Sylvie Moreau, Özge Uluçkan, Geraldine S. Pinkus, Zuzana Tóthová, Alessandra F. Nascimento, Jon C. Aster and Julie L. Prior. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.